On Sept. 9, 2025, the U.S. Department of Health and Human Services and the Food and Drug Administration jointly announced a crackdown on deceptive direct-to-consumer (DTC) pharmaceutical advertising, including promotion...more
9/17/2025
/ Advertising ,
Department of Health and Human Services (HHS) ,
Enforcement Actions ,
Food and Drug Administration (FDA) ,
Influencers ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs ,
Regulatory Oversight ,
Rulemaking Process ,
Social Media
On March 31, 2025, the U.S. District Court for the Eastern District of Texas, in American Clinical Laboratory Association v. U.S. Food and Drug Administration, vacated the U.S. Food and Drug Administration’s (FDA’s) May 6,...more
On Feb. 18, 2025, the U.S. Court of Appeals for the First Circuit adopted the “but for” causality standard for violations of the federal Anti-Kickback Statute (AKS) that give rise to violations of the federal False Claims Act...more
The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval Program, including a focus on product withdrawal and requirements for ongoing confirmatory...more
In response to an outbreak of the H5N1 strain of bird flu among dairy cows in at least 15 states, the U.S. Department of Agriculture (USDA) issued a new federal order (the Order) requiring dairy farms and other entities...more